FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic.
Company Location
9168 Wooden Road
Raleigh
NC
27617-8203
Phone
(919) 294-6472
County
Region
Company Details
Year founded
2013
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
FLAG-003, a small molecule which has anti-angiogenic and anti-tubulin properties for the treatment of Glioma. FLAG also has a series of compounds which are GARFTase and SHMT-2 inhibitors, which are First-in-Class purine synthesis inhibitors.